Skip to main content
Erschienen in: Journal of Clinical Immunology 4/2024

01.04.2024 | Research

Inborn Errors of Immunity in Jordan: First Report from a Tertiary Referral Center

verfasst von: Raed Alzyoud, Motasem Alsuweiti, Heba Maaitah, Boshra Aladaileh, Mohammed Noubani, Hamazh Nsour

Erschienen in: Journal of Clinical Immunology | Ausgabe 4/2024

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Inborn errors of immunity (IEI) are a heterogeneous group of diseases with variable clinical phenotypes. This study was conducted to describe the epidemiology, clinical presentations, treatment, and outcome of IEI in Jordanian children.

Methods

A retrospective data analysis was conducted for children under 15 years diagnosed with IEI from the pediatric Allergy, Immunology, and Rheumatology Division-based registry at Queen Rania Children’s Hospital, Amman, Jordan, between 2010 and 2022.

Results

A total of 467 patients, 263 (56.3%) males and 204 (43.7%) females, were diagnosed with IEI. The mean age at symptom onset was 18 months (1 week to 144 months), a positive family history of IEI was reported in 43.5%, and the consanguinity rate was 47.9%. The most common IEI category was immunodeficiencies affecting cellular and humoral immunity at 33.2%, followed by predominantly antibody deficiencies at 16.9%. The overall median diagnostic delay (range) was 6 (0-135) months; patients with a positive family history of IEI had a statistically significant shorter diagnostic delay. Pulmonary and gastrointestinal clinical features were the most common at 55.2% and 45.6%, respectively. The overall mortality was 33.2%; the highest rate was reported in severe combined immunodeficiency at 56.2%.

Conclusions

The high minimal estimated IEI prevalence at 16.2/100,000 Jordanian children compared to the regional and worldwide data, with the diversities in clinical presentation and distribution of IEI categories in our cohort point to unique features of IEI in Jordanian children, call for national registry establishment, regional and international collaborative networks.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
4.
Zurück zum Zitat Tangye SG, Al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A et al. Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2020;40(1):24–64. doi: 10.1007/s10875-019-00737-x. Epub 2020 Jan 17. Erratum in: J Clin Immunol. 2020; PMID: 31953710; PMCID: PMC7082301. Tangye SG, Al-Herz W, Bousfiha A, Chatila T, Cunningham-Rundles C, Etzioni A et al. Human Inborn Errors of Immunity: 2019 Update on the Classification from the International Union of Immunological Societies Expert Committee. J Clin Immunol. 2020;40(1):24–64. doi: 10.1007/s10875-019-00737-x. Epub 2020 Jan 17. Erratum in: J Clin Immunol. 2020; PMID: 31953710; PMCID: PMC7082301.
10.
Zurück zum Zitat Islam MM, Ababneh FM, Khan MHR. CONSANGUINEOUS MARRIAGE IN JORDAN: AN UPDATE. J Biosoc Sci. 2018;50(4):573–8. Epub 2017 Aug 10. PMID: 28793942.CrossRefPubMed Islam MM, Ababneh FM, Khan MHR. CONSANGUINEOUS MARRIAGE IN JORDAN: AN UPDATE. J Biosoc Sci. 2018;50(4):573–8. Epub 2017 Aug 10. PMID: 28793942.CrossRefPubMed
11.
Zurück zum Zitat Habahbeh ZM, Abu-Shukair ME, Almutereen MA, Alzyoud RM, Wahadneh AM. Primary antibody deficiencies at Queen Rania Children Hospital in Jordan: single center experience. Iran J Immunol. 2014;11(1):49–58. PMID: 24632588.PubMed Habahbeh ZM, Abu-Shukair ME, Almutereen MA, Alzyoud RM, Wahadneh AM. Primary antibody deficiencies at Queen Rania Children Hospital in Jordan: single center experience. Iran J Immunol. 2014;11(1):49–58. PMID: 24632588.PubMed
13.
16.
Zurück zum Zitat Abolhassani H, Azizi G, Sharifi L, Yazdani R, Mohsenzadegan M, Delavari S et al. Global systematic review of primary immunodeficiency registries. Expert Rev Clin Immunol. 2020;16(7):717–732. doi: 10.1080/1744666X.2020.1801422. PMID: 32720819. Abolhassani H, Azizi G, Sharifi L, Yazdani R, Mohsenzadegan M, Delavari S et al. Global systematic review of primary immunodeficiency registries. Expert Rev Clin Immunol. 2020;16(7):717–732. doi: 10.1080/1744666X.2020.1801422. PMID: 32720819.
22.
Zurück zum Zitat Bousfiha AA, Errami A, Jeddane L, Mellouli F, Reda SM, Adeli M, et al. Primary immunodeficiencies: Epidemiology in the Maghreb. Tunis Med. 2018 Oct-Nov;96(10–11):672–7. PMID: 30746660. Bousfiha AA, Errami A, Jeddane L, Mellouli F, Reda SM, Adeli M, et al. Primary immunodeficiencies: Epidemiology in the Maghreb. Tunis Med. 2018 Oct-Nov;96(10–11):672–7. PMID: 30746660.
31.
32.
Zurück zum Zitat Thalhammer J, Kindle G, Nieters A, Rusch S, Seppänen MRJ, Fischer A, et al. European Society for Immunodeficiencies Registry Working Party. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations. J Allergy Clin Immunol. 2021;148(5):1332–e13415. Epub 2021 Apr 23. PMID: 33895260.CrossRefPubMed Thalhammer J, Kindle G, Nieters A, Rusch S, Seppänen MRJ, Fischer A, et al. European Society for Immunodeficiencies Registry Working Party. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations. J Allergy Clin Immunol. 2021;148(5):1332–e13415. Epub 2021 Apr 23. PMID: 33895260.CrossRefPubMed
34.
Zurück zum Zitat Al-Tamemi S, Al-Zadjali S, Bruwer Z, Naseem SUR, Al-Siyabi N, ALRawahi M et al. Genetic Causes, Clinical Features, and Survival of Underlying Inborn Errors of Immunity in Omani Patients: a Single-Center Study. J Clin Immunol. 2023;43(2):452–465. doi: 10.1007/s10875-022-01394-3. Epub 2022 Nov 3. PMID: 36324046. Al-Tamemi S, Al-Zadjali S, Bruwer Z, Naseem SUR, Al-Siyabi N, ALRawahi M et al. Genetic Causes, Clinical Features, and Survival of Underlying Inborn Errors of Immunity in Omani Patients: a Single-Center Study. J Clin Immunol. 2023;43(2):452–465. doi: 10.1007/s10875-022-01394-3. Epub 2022 Nov 3. PMID: 36324046.
36.
Zurück zum Zitat Galal N, Meshaal S, Elhawary R, ElAziz DA, Alkady R, Lotfy S, et al. Patterns of primary Immunodeficiency disorders among a highly Consanguineous Population: Cairo University Pediatric Hospital’s 5-Year experience. J Clin Immunol. 2016;36(7):649–55. https://doi.org/10.1007/s10875-016-0314-1. Epub 2016 Aug 2. PMID: 27484503.CrossRefPubMed Galal N, Meshaal S, Elhawary R, ElAziz DA, Alkady R, Lotfy S, et al. Patterns of primary Immunodeficiency disorders among a highly Consanguineous Population: Cairo University Pediatric Hospital’s 5-Year experience. J Clin Immunol. 2016;36(7):649–55. https://​doi.​org/​10.​1007/​s10875-016-0314-1. Epub 2016 Aug 2. PMID: 27484503.CrossRefPubMed
37.
Zurück zum Zitat Bousfiha AA, Jeddane L, El Hafidi N, Benajiba N, Rada N, El Bakkouri J, et al. Moroccan Society for Primary Immunodeficiencies (MSPID). First report on the Moroccan registry of primary immunodeficiencies: 15 years of experience (1998–2012). J Clin Immunol. 2014;34(4):459–68. https://doi.org/10.1007/s10875-014-0005-8. Epub 2014 Mar 12. PMID: 24619622.CrossRefPubMed Bousfiha AA, Jeddane L, El Hafidi N, Benajiba N, Rada N, El Bakkouri J, et al. Moroccan Society for Primary Immunodeficiencies (MSPID). First report on the Moroccan registry of primary immunodeficiencies: 15 years of experience (1998–2012). J Clin Immunol. 2014;34(4):459–68. https://​doi.​org/​10.​1007/​s10875-014-0005-8. Epub 2014 Mar 12. PMID: 24619622.CrossRefPubMed
39.
Zurück zum Zitat Al-Tamemi S, Naseem SU, Al-Siyabi N, El-Nour I, Al-Rawas A, Dennison D. Primary Immunodeficiency Diseases in Oman: 10-Year Experience in a Tertiary Care Hospital. J Clin Immunol. 2016;36(8):785–792. https://doi.org/10.1007/s10875-016-0337-7. Epub 2016 Oct 3. PMID: 27699572. Al-Tamemi S, Naseem SU, Al-Siyabi N, El-Nour I, Al-Rawas A, Dennison D. Primary Immunodeficiency Diseases in Oman: 10-Year Experience in a Tertiary Care Hospital. J Clin Immunol. 2016;36(8):785–792. https://​doi.​org/​10.​1007/​s10875-016-0337-7. Epub 2016 Oct 3. PMID: 27699572.
40.
Zurück zum Zitat Baris S, Abolhassani H, Massaad MJ, Al-Nesf M, Chavoshzadeh Z, Keles S, et al. The Middle East and North Africa Diagnosis and management guidelines for inborn errors of immunity. J Allergy Clin Immunol Pract. 2023;11(1):158–e18011. Epub 2022 Oct 17. PMID: 36265766.CrossRefPubMed Baris S, Abolhassani H, Massaad MJ, Al-Nesf M, Chavoshzadeh Z, Keles S, et al. The Middle East and North Africa Diagnosis and management guidelines for inborn errors of immunity. J Allergy Clin Immunol Pract. 2023;11(1):158–e18011. Epub 2022 Oct 17. PMID: 36265766.CrossRefPubMed
44.
Zurück zum Zitat Gennery AR, Slatter MA, Grandin L, Taupin P, Cant AJ, Veys P et al. Inborn Errors Working Party of the European Group for Blood and Marrow Transplantation; European Society for Immunodeficiency. Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better? J Allergy Clin Immunol. 2010;126(3):602 – 10.e1-11. doi: 10.1016/j.jaci.2010.06.015. Epub 2010 Jul 31. PMID: 20673987. Gennery AR, Slatter MA, Grandin L, Taupin P, Cant AJ, Veys P et al. Inborn Errors Working Party of the European Group for Blood and Marrow Transplantation; European Society for Immunodeficiency. Transplantation of hematopoietic stem cells and long-term survival for primary immunodeficiencies in Europe: entering a new century, do we do better? J Allergy Clin Immunol. 2010;126(3):602 – 10.e1-11. doi: 10.1016/j.jaci.2010.06.015. Epub 2010 Jul 31. PMID: 20673987.
45.
Zurück zum Zitat Moodley S, Goddard E, Levin M, Scott C, Van Eyssen A, Davidson A et al. A retrospective description of primary immuno-deficiency diseases at Red Cross War Memorial Children’s Hospital, Cape Town, South Africa, 1975–2017. S Afr Med J. 2020;110(3):197–203. https://doi.org/10.7196/SAMJ.2020.v110i3.14200. PMID: 32657696. Moodley S, Goddard E, Levin M, Scott C, Van Eyssen A, Davidson A et al. A retrospective description of primary immuno-deficiency diseases at Red Cross War Memorial Children’s Hospital, Cape Town, South Africa, 1975–2017. S Afr Med J. 2020;110(3):197–203. https://​doi.​org/​10.​7196/​SAMJ.​2020.​v110i3.​14200. PMID: 32657696.
47.
Zurück zum Zitat Olaya M, Cleves D, Guzmán T, Torres-Canchala L, Pachajoa H, Medina-Valencia D et al. Demographic and clinical characterization of pediatric group patients with inborn errors of the immune system in a Colombian tertiary hospital. Allergol Immunopathol (Madr). 2022;50(4):17–22. https://doi.org/10.15586/aei.v50i4.55. PMID: 35789399. Olaya M, Cleves D, Guzmán T, Torres-Canchala L, Pachajoa H, Medina-Valencia D et al. Demographic and clinical characterization of pediatric group patients with inborn errors of the immune system in a Colombian tertiary hospital. Allergol Immunopathol (Madr). 2022;50(4):17–22. https://​doi.​org/​10.​15586/​aei.​v50i4.​55. PMID: 35789399.
Metadaten
Titel
Inborn Errors of Immunity in Jordan: First Report from a Tertiary Referral Center
verfasst von
Raed Alzyoud
Motasem Alsuweiti
Heba Maaitah
Boshra Aladaileh
Mohammed Noubani
Hamazh Nsour
Publikationsdatum
01.04.2024
Verlag
Springer US
Erschienen in
Journal of Clinical Immunology / Ausgabe 4/2024
Print ISSN: 0271-9142
Elektronische ISSN: 1573-2592
DOI
https://doi.org/10.1007/s10875-024-01709-6

Weitere Artikel der Ausgabe 4/2024

Journal of Clinical Immunology 4/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden!

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.